Related Articles
2‑D08 mediates notable anticancer effects through multiple cellular pathways in uterine leiomyosarcoma cells
Two faces of the estrogen metabolite 2-methoxyestradiol in vitro and in vivo
Downregulation of miR‑10b‑5p facilitates the proliferation of uterine leiomyosarcoma cells: A microRNA sequencing‑based approach
Hepatocyte growth factor activator inhibitors (HAI-1 and HAI-2) are potential targets in uterine leiomyosarcoma
The inhibition of tyrosine kinase receptor signalling in leiomyosarcoma cells using the small molecule kinase inhibitor PTK787/ZK222584 (Vatalanib®)